The PurpleLab^® Resource Center

For all the buzz around the Inflation Reduction Act (IRA), opinions on its impact are sharply divided – especially in the life sciences sector. Critics argue that the IRA’s drug pricing provisions, particularly Medicare price negotiation, will stifle innovation by reducing incentives for pharmaceutical companies to invest in research and development.  But these concerns don’t…

Nurse Practitioners (NPs) and Physician Assistants (PAs) are no longer just “support” staff for physicians. These clinicians are now taking on much bigger roles in patient care, including the ability to prescribe medications without physician oversight.  The COVID-19 pandemic accelerated the already growing trend of expanding NPs’ and PAs’ scope of practice. Now, five years…

Mapping the patient journey has become more complex, but also more critical to understand what is actually happening in the treatment or therapeutic landscape. This webinar will explore how leveraging PurpleLab’s integrated data sources, including claims and Social Determinants of Health (SDOH), can unlock critical insights for commercial, market access, and medical affairs teams.